Peetz Christopher, CEO, reported a transaction classified as grant at Mirum Pharmaceuticals, Inc. involving 153550.000000 shares for an estimated $0.00. Reported holdings after the transaction were 153550.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
CHIEF EXECUTIVE OFFICER
1/4th of the shares vest one year after January 21, 2025 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the…
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-y…
On January 31, 2023, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 21, 2025, performance criteri…
0 other filings
0 recent txs